Сахар из можжевеловой ягоды: [брошюра]

0|3|Сахар из можжевеловой ягоды [c. 3]0|7|Инструкция по сбору, сушке и хранению можжевеловой ягоды [c. 7]0|8|Инструкция по переработке можжевеловой ягоды на сладкие экстракты и сироп для школ, госпиталей, столовых и домашнего быта [c. 8]0|11|Использование экстракта и сиропа [c. 11

Parent misunderstandings linked to important issues as identified in the interviews.

<p>(N = 41 families).</p

Demographic and trial participation trajectory of parents.

<p>(N = 41 families).</p

Invitations to elicit parents’ questions in parent-practitioner discussions about clinical trials.

<p>Invitations to elicit parents’ questions in parent-practitioner discussions about clinical trials.</p

Parents’ agenda items identified in trial recruitment discussions and interview analysis.

<p>(N = 41 families).</p

Additional file 6: Appendix 6. of A patient and public involvement (PPI) toolkit for meaningful and flexible involvement in clinical trials – a work in progress

PPI Remit TSC Public Contributor. (PDF 807 kb

Additional file 7: Appendix 7. of A patient and public involvement (PPI) toolkit for meaningful and flexible involvement in clinical trials – a work in progress

Participant Information Review Question Bank. (PDF 441 kb

Scenario A: If a child of mine had a serious infection and needed emergency fluid treatment.

<p>Figures are n(%). Missing responses: Question 1∶1 bereaved; Question 2∶1 bereaved and 1 recovered; Question 3∶1 bereaved; Question 4; 1 bereaved.</p

Additional file 1: of A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial)

Statistical analysis plan (PDF 607 kb

Scenario B: If a child could not be resuscitated and unfortunately died in the emergency department we would want to tell the parents that their child had been given the fluid as part of a clinical trial of emergency treatments.

<p>Figures are n(%). Missing responses: Question 5∶1 bereaved; Question 6∶1 bereaved.</p